TREAT PTSD Act

This bill requires the VA and Department of Defense to provide stellate ganglion block therapy to eligible veterans and active-duty military members diagnosed with PTSD who have given informed consent after learning about the treatment's risks and benefits. It applies specifically to veterans enrolled in VA care and service members in the TRICARE program who meet the diagnosis and consent criteria. The bill mandates that VA and DoD update their joint clinical guidelines within 180 days to include this therapy option and its clinical indicators. The policy change takes effect 180 days after enactment, making this therapy a covered benefit through existing VA and military healthcare systems.